Medicine

Hibernation scientific research used to handle being overweight and also modify metabolic rate

.Attribute Medication, Published online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy recogni...

CAR- T as well as mobile genetics therapies are also pricey

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care ma...

The that genomics program of work with reasonable application of human genomics for worldwide health

.The publication of the initial draft of the human genome pattern in 20011 was observed by the arriv...

A time-stratified, case\u00e2 $ \"crossover study of warmth visibility as well as perinatal mortality from 16 medical facilities in sub-Saharan Africa

.One of 138,015 hospital-based singleton births in four sub-Saharan African nations, we monitored do...

Advancing worldwide antibiotic research study, advancement and gain access to #.\n\nMurray, C. J. L. et cetera. Global worry of microbial antimicrobial resistance in 2019: a step-by-step evaluation. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. In the direction of certain dedications and activity in the response to antimicrobial protection. Global Frontrunners Team on Antimicrobial Resistance https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). World Health And Wellness Institution. WHO publishes listing of micro-organisms for which brand-new antibiotics are actually urgently needed to have. Globe Health and wellness Association https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Wellness Company. WHO microbial top priority microorganisms checklist, 2024: microbial virus of hygienics relevance to lead analysis, development and approaches to prevent and regulate antimicrobial protection. Planet Health and wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative entry. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle.com Scholar\u00c2.\nGlobe Health And Wellness Association. 2023 antibacterial brokers in medical and also preclinical progression: a guide as well as evaluation. Planet Health Company https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et al. AMR Customer review. May 19, 2016 \u00e2 $\" Taking on drug-resistant diseases internationally: final record as well as suggestions. Assessment on Antimicrobial Protection https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Consortium. DRIVE-AB results: reports as well as rundown. Drive abdominal muscle https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Appearing the wall surface: a call for concurrent action on antibiotics research and development. Boston ma Consulting Team https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Concise 51: How can the EU help sustainable advancement and access to efficient prescription antibiotics? policy options for existing and new medicines. International Observatory on Health And Wellness Solutions as well as Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Antibiotic use as well as resistance\u00e2 $\" showing the obvious. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health Institution. 2021 AWaRe classification. That access, watch, reserve, category of prescription antibiotics for examination and also surveillance of making use of. World Wellness Association https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Facility for Condition Avoidance and Management. Antimicrobial resistance aim ats: exactly how can our company reach them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Planet Health And Wellness Organization. Absence of innovation readied to threaten antibiotic performance and wellness increases. Globe Health and wellness Institution https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et al. Exactly how antimicrobial resistance is linked to weather change: an outline of pair of intertwined worldwide problems. Int. J. Environ. Res. Hygienics twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial infections: our company need to have critical action and also investment that focus on the weakest web link. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Health Organization. Booster shot protection. Globe Health Company https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Contamination prevention and also command in low-resource settings: the need for the local area, the contextual as well as the practical. Affect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Problems of applying antimicrobial stewardship devices in reduced to center revenue nations (LMICs). Contaminate. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nAminov, R. A brief past of the antibiotic period: lessons knew and difficulties for the future. Face. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K. et cetera. Person get access to in 14 high-income nations to brand-new antibacterials permitted due to the US Food and Drug Administration, European Medicines Company, Japanese Pharmaceuticals and also Medical Devices Agency, or Health Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Health And Wellness Organization. 2021 antibacterial brokers in professional as well as preclinical development: a summary and also analysis. Planet Health Association https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Antibiotics: the business economics need to assist the scientific research. Attribute 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of technology in antibacterial rehabs. Medical Technology Institution https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et al. Analyzing specialist usage of next-generation antibiotics against resisting Gram-negative diseases in united state hospitals: a retrospective accomplice research study. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nThomas, D. &amp Wessel, C. The condition of advancement in anti-bacterial therapeutics. Medical Development Company https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A systematic review and critical analysis of reward approaches for discovery as well as advancement of unique prescription antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle Scholar\u00c2.\nHealth Emergency Preparedness as well as Response Authorization. R &amp d of clinical countermeasures. European Commission https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). International Payment. Pre-draft proposition for an International relationship under Horizon Europe One Health And Wellness Antimicrobial Resistance. International Commission https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Worldwide Prescription Antibiotic R &amp D Partnership. Entasis Therapies and also the Global Anti-biotic Investigation &amp Development Relationship to cultivate a new therapy for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of market- as well as non-industry-sponsored clinical tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Wellness Company. Lot of professional trial registrations through place, ailment, period of growth, grow older as well as sex of trial individuals (1999\u00e2 $ \"2022). Globe Wellness Company https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Global Prescription Antibiotic Research and Development Collaboration. NeoSept1: a research to determine the rank of existing as well as brand-new prescription antibiotics mixtures to address newborn babies that reside in medical facility along with serious sepsis. ISRCTN windows registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Firm of Canada. Federal government of Canada brings in necessary investment to overcome antimicrobial protection (AMR), Authorities of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). International Prescription Antibiotic Experimentation Partnership. Japan government backing supports GARDP\u00e2 $ s attempts to respond to antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Structure. Novo Nordisk Foundation companions along with CARB-X to overcome drug-resistant diseases. novo nordisk base https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Health And Wellness and Digital Manager Agency. Research on carrying AMR clinical countermeasures to the market place. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Estimating the suitable measurements of worldwide pull rewards for antibacterial medications. Health Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Sizing a market entry incentive for the progression of brand-new prescription antibiotics. Harvard Kennedy Institution https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Field incentives and antibiotic resistance: an overview to the antibiotic sensitivity incentive. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. A determined USG progressed dedication for subscription-based buying of unfamiliar antimicrobials as well as its anticipated roi. Center for Global Development https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 investments in brand new anti-biotics will pay off \u00e2 $\" for everybody. Workplace of Health Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS boosts fight against deadly infections following successful world-first fly. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Congress. S. 1355 \u00e2 $\" PASTEUR Process of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Commission. Reform of the EU pharmaceutical legalisation. European Payment https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Compensation models to tackle market failings for antimicrobials: techniques consumed France, Germany, Sweden, the UK, and the United States. Health Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Federation of Drug Manufacturers and Affiliations. From resistance to resilience: what could the potential antibiotic pipeline resemble? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Global AMR R&ampD Center &amp World Health Association. Incentivising the development of brand new antibacterial procedures: 2023 progress report due to the International AMR R&ampD Hub and also WHO. Worldwide AMR R&ampD Center https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Vocalist, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK registration model for anti-biotics considered productive? Lancet Micro organism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unfamiliar stimulations for the advancement as well as keeping on the marketplace of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et cetera. Global, local, and national reasons for little one death in 2000\u00e2 $ \"thirteen, along with projections to educate post-2015 top priorities: an improved systematic study. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nQuadri, F. et al. Anti-bacterial drug shortages from 2001 to 2013: ramifications for clinical exercise. Clin. Infect. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et al. The French coverage device for medication deficiencies: explanation and patterns from 2012 to 2018: an empirical retrospective research. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et cetera. Evaluation of WHO antibiotic usage and accessibility targets in 76 countries, 2000\u00e2 $ \"15: a study of pharmaceutical purchases information. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Combating the counterfeits: taking on substandard and also falsified medications. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it getting much easier to acquire antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nBlack Community for Research Laboratory Medicine. Plan brief and infographics on antimicrobial protection (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic intake for human usage in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research study. Trop. Med. Corrupt. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial usage: review of main warehouses products to in-patient treatment wellness facilities coming from 2017 to 2019 in Uganda. Trop. Med. Infect. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et cetera. Variants in the consumption of antimicrobial medicines in the International area, 2014\u00e2 $ \"2018: findings as well as ramifications coming from ESAC-Net and WHO Europe. Face. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et al. Drug scarcity: reasons, impact, and also relief approaches. Front end. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Patient access in 14 high-income nations to brand new antibacterials accepted by the United States Fda, European Medicines Organization, Japanese Pharmaceuticals and Medical Tools Agency, or even Health Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et cetera. Lost antibiotics: a follow-up stock study in Europe, the USA, Canada and Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health and wellness innovation for international health. Br. Med. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Sector Alliance. The 2023 AMR Market Partnership development questionnaire: manufacturing as well as the environment. amr Sector Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Invasion, D. &amp Gaule, P. Can clinical products be actually built on a non-profit manner? Exploring item growth collaborations for neglected diseases. Sci. Public law 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et al. Reboot biomedical R&ampD in the international social rate of interest. Nature 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Illness Management and also Avoidance. Africa CDC leads daring relocate to protect Africa\u00e2 $ s wellness future through generating a 50 billion dollar clinical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Carnage, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Haggling public-health copyright licensing contracts to increase accessibility to health innovations: an insider\u00e2 $ s account. BMJ Chunk. Wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New company styles for r &amp d with affordability needs are actually needed to obtain reasonable costs of medicines. Br. Medication. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nCombating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator. Stewardship and get access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Worldwide Prescription Antibiotic Research and Development Relationship. Shinogi, GARDP as well as CHAI announce landmark license and collaboration contracts to manage microbial infections by broadening accessibility to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Sector Alliance. Leaving behind the lab: tracking the decrease in AMR R&ampD professionals. amr Business Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Wellness Ministers. G7 Health Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 call to activity on antimicrobial protection. G7G20 Files Data bank https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). International Union on Getting Older &amp Contagious Health Conditions Culture of The United States. 2024 AMR preparedness mark progress report. Assessing government activity on AMR policy. International Coalition on Aging https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items and also Horticulture Organization of the United Nations, United Nations Atmosphere Programme, Planet Health And Wellness Institution &amp. Planet Company for Creature Health And Wellness. Worldwide data bank for tracking antimicrobial protection (AMR): nation self-assessment survey (TrACSS). WHO https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Truck Katwyk, S. R. &amp Outterson K. Overview: AMR belongs in the wi...

Integrating liver endpoints in medical tests of cardio and also renal health condition

.Attributes Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspec...

FALSE:: ERROR: UNSUPPORTED ENCODING...

Artificial knowledge guided screening for cardiomyopathies in an obstetric population: a practical randomized professional test

.Test design and oversightThe Screening for PEripartum Cardiomyopathies with Artificial Intelligence...

Sustained HIV remission after allogeneic hematopoietic stem cell transplant along with wild-type CCR5 benefactor tissues

.Attribute Medicine, Released online: 02 September 2024 doi:10.1038/ s41591-024-03277-zHIV remission...

Senolytics target cell senescence-- however can they reduce getting older?

.In the 1960s, US anatomist Leonard Hayflick noticed that replicative tissues possess a minimal lot ...